<?xml version="1.0" encoding="UTF-8"?>
<ref id="ppat.1008820.ref079">
 <label>79</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Yaqinuddin</surname>
   <given-names>A</given-names>
  </name>, 
  <name>
   <surname>Kashir</surname>
   <given-names>J</given-names>
  </name>. 
  <article-title>Innate immunity in COVID-19 patients mediated by NKG2A receptors, and potential treatment using Monalizumab, Cholroquine, and antiviral agents</article-title>. 
  <source>Med Hypotheses</source>. 
  <year>2020</year>;
  <volume>140</volume>:
  <fpage>109777</fpage> Epub 2020/04/29. 
  <pub-id pub-id-type="doi">10.1016/j.mehy.2020.109777</pub-id>
  <?supplied-pmid 32344314?>
  <pub-id pub-id-type="pmid">32344314</pub-id>
 </mixed-citation>
</ref>
